Stockreport

Nasus Pharma CEO Issues 2025 Letter to Shareholders

Nasus Pharma Ltd. Ordinary Shares  (NSRX) 
PDF TEL AVIV, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma", “Nasus” or the "Company"), a clinical-stage pharmaceutical company [Read more]